Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109

9518447302
|
Calling
Whatsapp

Home/All Molecules/Linezolid

Linezolid Range

Comprehensive Linezolid portfolio for Franchise & Manufacturing.

Category
linezolid
Total Formulations
8
Available Forms
Dry Syrup, Infusion, Tablets
Featured Combinations
Browse by Form
Why Partner with Us?
About Molecule
Franchise FAQ

Expand Your Business with Our Multiple Divisions

General and OTC
Critical Care Injections
Gynae and Infertility care
Respiratory Care
Pediatric Medicines
Derma Care
Neuro care
Eye and Ear care
Ayurvedic Herbal care
Cardiac Diabetic Care
Cardiac Diabetic Care
Cardiac Diabetic Care

Browse Linezolid portfolio by Dosage Form

Dry Syrup
Infusion
Tablets

The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Linezolid batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Linezolid PCD Pharma Franchise Company

Linezolid PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified Linezolid PCD pharma franchise company offering a portfolio of 8 Linezolid formulations. We supply quality-assured, consistently manufactured Linezolid products to franchise partners and distributors across India on a monopoly (district-wise) basis.

What is Linezolid?

Linezolid is a synthetic antibiotic of the oxazolidinone class that stops bacterial growth by binding the 23S ribosomal RNA of the 50S subunit and blocking the formation of the initiation complex for protein synthesis. It is active against resistant Gram-positive organisms such as MRSA and VRE and is used in drug-resistant tuberculosis. Reference: PubChem.

Available Forms

Our Linezolid range is available as Dry Syrup, Infusion and Tablets, allowing partners to serve diverse prescriptions from a single reliable supplier.

Therapeutic Applications of Linezolid

Linezolid is indicated for serious Gram-positive infections including MRSA and VRE infections, nosocomial and community-acquired pneumonia, complicated skin and soft-tissue infections, and as part of regimens for drug-resistant tuberculosis. It is commonly prescribed by physicians, pulmonologists, intensivists and infectious-disease specialists.

Why Linezolid is a High-Potential Molecule for Distributors

As a reserve antibiotic for multidrug-resistant Gram-positive infections and drug-resistant TB, Linezolid commands premium value and steady demand from hospitals and TB programmes. Its availability in oral (tablet, dry syrup) and infusion forms supports step-down therapy, making it a high-margin institutional molecule for distributors.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers exclusive monopoly rights, WHO-GMP certified and DCGI-approved formulations, attractive promotional inputs, and the backing of a network of 1000+ franchise partners. Our transparent pricing and dependable supply chain help distributors build a profitable long-term business.

References

  1. WHO Model List of Essential Medicines
  2. PubChem - Linezolid
  3. PubMed - Linezolid research

Aceclofenac in Modern Clinical Practice

Our formulations of Linezolid find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:

FAQ about Linezolid in PCD Franchise

Start Your Linezolid Franchise with Cafoli Lifecare. Secure monopoly rights for your district and partner with a WHO-GMP certified manufacturer. Call 9518447302 or email info@cafoli.in to request your price list and product details.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 8 Linezolid formulations including dry syrup, infusion and tablets, supporting both oral and intravenous therapy.

Yes. Cafoli grants exclusive district-wise monopoly rights for Linezolid. A valid Drug License and GST registration are required.

Physicians, pulmonologists, intensivists and infectious-disease specialists prescribe Linezolid for resistant Gram-positive infections and drug-resistant tuberculosis.

As a reserve antibiotic for MRSA, VRE and drug-resistant TB, it commands premium pricing and steady hospital and TB-programme demand, with oral and infusion forms enabling step-down therapy.

A valid Drug License and GST registration. After verification, Cafoli issues a monopoly agreement and provides promotional inputs to support your launch.

Our Manufacturing Partners

Our Manufacturing Partner | Akums Drugs and Pharmaceuticals
Our Manufacturing Partner | Pharmaceuticals Pvt. Ltd.
Our Manufacturing Partner | Tirupati
Our Manufacturing Partner | Swess-Garniers
Our Manufacturing Partner | Windlas Biotech Limited
Our Manufacturing Partner | Hetero Pharmaceutical company
Our Manufacturing Partner | Unimarck
Our Manufacturing Partner | mascort
Our Manufacturing Partner | Synokem Pharmaceuticals Limited
Our Manufacturing Partner | Biodeal Pharmaceuticals Limited